The anti-inflammatory activities of a prepared isoegomaketone 3a and its derivatives 3b-3f were evaluated in RAW 264.7 cells. Among these, the compound 3d was displayed the most potent inhibitory activities against production of nitric oxide, monocyte chemoattractant protein-1 and interleukin-6. Based on these results, the abilities of compounds 3a-3f to modulate NF-κB and AP-1-mediated gene transcription using a luciferase reporter assay were investigated. The transcriptional activities of NF-κB and AP-1 decreased when pretreated with 3a-3f. Interestingly, at 10 μM, compound 3d markedly suppressed the lipopolysaccharide-induced NF-κB and activator protein-1 DNA binding activities. Some preliminary structure-activity relationships were proposed that may provide a direction for further study.
An efficient conversion of ketones to .alpha.,.beta.-unsaturated ketones
미소장
2
Toll-like receptors in the induction of the innate immune response.
미소장
3
Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters.
미소장
4
Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
미소장
5
Isoegomaketone inhibits lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophages through the heme oxygenase-1 induction and inhibition of the interferon-beta-STAT-1 pathway.
미소장
6
Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation
미소장
7
Manning, A. M. and Mercurio, F., Transcription inhibitors in inflammation. Expert Opin. Investig. Drugs, 6, 555-567 (1997).
미소장
8
Melgarejo, E., Medina, M. A., Sanchez-Jimenez, F., and Urdiales, J. L., Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int. J. Biochem. Cell Biol., 41, 998-1001 (2009).
미소장
9
O'Neill, L. A., Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov., 5, 549-563 (2006).
미소장
10
Biotechnology Journal 10/2010
미소장
11
Reinhart, K. and Karzai, W., Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit. Care Med., 29, S121-S125 (2001).
미소장
12
Shaulian, E. and Karin, M., AP-1 as a regulator of cell life and death. Nat. Cell Biol., 4, E131-E136 (2002).